Proven Partner
for Biopharma
Clinical-Grade AI Tools for Biomarker Development, Trial Enablement & Companion Diagnostics
Why Leading Pharma Companies Partner with Ibex
Unlike AI vendors focused solely on research, Ibex combines best-in-class AI technology with proven real-world clinical deployment, enabling partners to move from concept to clinical impact with a single strategic partner.
Proven End-to-End Expertise
Demonstrated ability to partner with biopharma from initial product development through global regulatory clearances to real-world clinical availability at scale.
Global Reach & Ecosystem Interoperability
Scanner, IMS, and clone-agnostic architecture maximizes diagnostic reach and future-proofs biopharma investments.
Best-in-Class Clinical-Grade AI
Proprietary foundation models and clinical-grade algorithms enable rapid development of best-in-class IHC stains.
Proven Big-Pharma Collaboration
Proven Big-Pharma Collaboration: Ibex partnered with leading global pharmaceutical companies on the development, clinical validation and early clinical adoption of AI-powered biomarker solutions, including HER2 assessment for breast cancer.
These collaborations demonstrate Ibex’s ability to support complex biomarker programs with the scientific rigor, regulatory foundation, and operational scalability required for global precision medicine initiatives.
Ibex supports biopharma from biomarker development to clinical deployment.
Accelerate both established and novel biomarker programs with AI designed for rapid prototyping, reproducible quantification, and scalable deployment. Ibex supports biomarker and scoring system development, threshold and cutoff optimization, patient stratification strategies, and validation of complex IHC biomarkers, whether starting from an early biomarker concept, an existing assay, or a partially developed algorithm.
Ibex’s platform operates within a mature Quality Management System (QMS) and regulatory framework designed to support clinical-grade and CDx-ready AI solutions. Our platform and development processes are built to meet the rigorous standards required for clinical validation, regulatory submissions, and commercialization.
Clinical deployment requires much more than algorithm development. Ibex solutions are already deployed in routine clinical practice worldwide across leading laboratories and healthcare systems. Our interoperable platform supports scalable deployment across multiple scanners and workflows to enable real-world clinical adoption at scale.
Biopharma Partnership Team
Ibex in the News
Interested in learning more about how Ibex can support your precision medicine strategy, biomarker programs, or companion diagnostic initiatives, or exploring ecosystem partnership opportunities? Please fill out the form below:
CANCER
DIAGNOSTICS
FOR ALL
